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In the present study, keratinocytes were coincubated with 
human neutrophils to determine whether or not an increase 
in leukotriene B4 formation can occur. Human keratinocytes 
used were cultured in serum-free, low-calcium medium, 
whereas neutrophils were purified from heparinized venous 
blood. After coincubations, formation of leukotriene B4 was 
determined by reversed-phase high-performance liquid c1lfo-
matography, coupled with its characteristic UV scan. Con-
firmation and quantification was by radioimmunoassay. Our 
data revealed that incubations of keratinocytes (1.5 X 106) 
alone stimulated with calcium ionophore resulted in no de-
tectable amounts of leukotriene B ... In contrast, incubations 
of neutrophils (5 X 106) alone resulted in the generation of 
62.2 ± 8.5 ng of L TB ... Coincubations of the neutrophils 
with keratinocytes (ratio 3: 1) resulted in a 56 -163% in-
crease in leukotriene B .. formation. To delineate the source of 
the newly formed leukotriene B .. , incubations of keratino-
T he leukotrienes formed from arachidonic acid (AA) by the 5-lipoxygenase (5-LO) have been implicated in the pathogenesis of skin inflammation, particularly in psoriasis. They are present in the lesional skin [1,2) and have the capability to induce skin inflammation 
after topical application [3,4). Furthermore, results from recent stud-
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Abbreviations: 
AA: arachidonic acid 
diHETE: dihydroxyeicosatetraenoic acid 
FCS: fetal calf serum 
HETE: hydroxyeicosatetraenoic acid 
HSA: human serum albumin 
KGM: keratinocyte growth medium 
5-LO: 5-lipoxygenase 
LT: leukotriene 
MeOH: methanol 
PBS: phosphate-buffered saline (Ca-H-- and Mg-H--free phosphate 
buffer, pH 7.4) 
PMN: polymorphonuclear leukocyte(s) 
RIA: radioimmunoassay 
RP-HPLC: reversed-phase high-performance liquid chromato-
graphy 
cytes with leukotriene A4 revealed that keratinocytes can 
transform leukotriene A .. into leukotriene B ... These latter 
findings indicate that although keratinocytes cannot directly 
metabolize arachidonic acid into leukotriene B .. via the 5-li-
poxygenase enzyme, they can transform neutrophil-derived 
leukotriene A .. into leukotriene B .. , thus indicating the possi-
ble existence of a putative keratinocyte-Ieukotriene A .. hy-
drolase. It is therefore reasonable to speculate that the kerati-
nocytes possess the capacity to generate leukotriene B .. in the 
epidermis when provided leukotriene A .. and thereby can 
amplify the inflammatory processes occurring during neu-
trophil exocytosis. These findings indicate that transcellular 
metabolism of arachidonic acid metabolites in the epidermis 
by keratinocytes and neutrophils may contribute to the high 
levels of leukotriene B .. in lesional skin of inflammatory skin 
diseases.] Invest DermatoI100:293-298, 1993 
ies have indicated that the treatment of psoriasis with a 5-LO inhibi-
tor resulted in the improvement of the disease, accompanied by the 
inhibition . o~ leukotriene (LT) B4 in the lesional skin" [5 ,6). The 
cellular ongm of L TB4 and the mechanism by which it is formed in 
the lesional skin of psoriasis has remained controversial. Human 
neutrophils (PMNs) have a very active 5-LO that transforms AA 
into large amounts of LTB4 after ill vitro incubation [7). In contrast, 
incubations of keratinocytes with AA have been reported to yield 
negligible amounts of LTB4-like material [8 ,9). LTB4 is formed 
from endogenous AA, which is released from the membrane phos-
pholipids by phospholipase A2 [10). Once released, free AA under-
goes enzymatic transformation via the 5-LO into 5-hydroperoxyei-
cosatetraenOic aCid [11) . This intermediate is either reduced to form 
5-hydroxyeicosatetraenoic acid (HETE) or further converted by the 
5-LO enzyme to LTA4 [11,12) . The resulting LTA4 is an unstable 
epoxide intermediate that, on the one hand, is further metabolized 
by LTA4-hydrolase to LTB4 and, on the other, by glutathione-S-
transferase to LTC4, LTD4, and LTE4. Alternatively, LTA4 can be 
hydrolyzed non-enzymatically to form 6-trallS-LTB4 and 12-epi-6-
trarls-LTB4 [7,13,14). 
The concept of transcellular metabolism of AA metabolites has 
recently generated much interest. For example, the interaction of 
• Camp R, Black AK, Cunningham F, Mallet AI, Greaves M: Pharmaco-
logical effects of topicallonapalene in psoriasis (abstr). J Invest Dermatol 
90:550, 1988. 
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monocytes with lymphocytes [15] or polymorphonuclear leuko-
cytes (PMNs) with other cells, such as platelets, endothelial cells, 
and erythrocytes [16-18], have all been reported to result in the 
transcellular transformation of LTA4 into L TB4 or LTC4, LTD4, 
and L TE4. It is therefore reasonable to speculate that L TB4 may be 
formed by a similar mechanism during skin inflammation, when 
PMNs infiltrate the epidermis. To answer this question, we investi-
gated whether the coincubation ofkeratinocytes with PMNs could 
result in altered metabolic transformation of AA. 
MATERIALS AND METHODS 
Materials The L T A4-methylester was obtained from Cascade 
Biochem Limited (Reading, England). Phosphate-buffered saline 
(PBS) was from Dulbecco's (Paisley, Scotland). Trypsin, bestatin, 
and calcium ionophore A23187 were all from Sigma Chemical Co. 
(St. Louis, MO). Authentic LTB4 was from Cayman Chemicals 
(Ann Arbor, MI); 6-tralls-L TB4 and 12-epi-6-tralls-L TB4 were gen-
erous gifts from Dr. J. Rokach, Merck Frost, Quebec, Canada. Or-
ganic solvents were all high-performance liquid chromatography 
(HPLC) grade from Merck (Darmstadt, Germany). 14C_AA, a New 
England Nuclear research product, was purchased from Du Pont 
(Kastrup, Denmark). Human serum albumin (HSA) was obtained 
from Nordisk Gentofte (Bagsvaed, Denmark). The low-calcium 
keratinocyte growth medium (KGM) from Gibco (Grand Island, 
NY) was fatty . aCid and serum free. RPMI 1640 medium was from 
Gibco, and culture dishes (25 cm2) were from Life Technologies 
(European I?ivisio~, Paisley, Scotland). Fetal calf serum (FCS) was 
from AI:1 Diagnostics (Aarhus, Denmark). The radioimmunoassay 
(RIA) bt for L TB4 was purchased from Amersham (Buckingham-
shire, England). 
Primary Cultures of Human Keratinocytes Human skin sam-
pl~s were obtained from patients undergoing plastic surgery. The 
skm samples were incubated at 37°C in 5 ml PBS containing 0.25% 
trypsin and 0.1 % glucose for 30 min. The incubation mixture was 
remo~ed and replaced with 5 ml of RPM I containing 2% FCS. The 
keratmocytes were then removed from the skin sample, and the cells 
were centrifuged at 800 g for 10 min and resuspended in KGM. The 
pelleted cells w~re counted and seed~d on culture dishes (25 cm2 / 
dish). The. keratmocytes were ogrown mlow-calcium KGM supple-
mented with AA (111M) at 37 C m an atmosphere of5% CO in air 
and a relative humidity of 80% until sub-confluent. The m~dium 
was changed three times weekly. 
Isolation of PMNs Blood was obtained from healthy human 
do~ors who had ~ot taken non-steroidal anti-inflammatory drugs 
dUring the precedmg 2 weeks. PMNs were prepared as previously 
described [19]. After isolation, the cells were suspended at a concen-
tration of 5 X 106/3 ml in KGM, pH 7.0 (containing 0.87 mM 
CaCI 2)· 
Incubation Procedures Culture dishes containing primary cul-
tures of sub-confluent keratinocytes alone, primary cultures of sub-
confluent keratinocytes with PMNs (2.5-10 X 106), or PMNs 
~lone (5 X 106) were pre-incubated, respectively, in KGM contain-
mg CaCl2 (0.87 mM) for 10 min at 37°C. Then, the cells were 
challenged with A23187 (final concentration 5 11M) dissolved in 
ethanol (final concentration < 1 %) and incubated for 5 min. The 
incubations were terminated by the addition of 2 vol of ice-cold 
methanol (MeOH). 
To ascertain whether or not KGM contained factor or factors that 
would alter LTB4 formation, fresh PMNs were incubated in a cul-
ture m~dium obtaine~ from A23187-stimulated keratinocytes. All 
l\1cubatlOns were slmdarly terminated by the addition of 2 vol of 
ice-cold MeOH. 
Pre-Labeling of Keratinocytes with I4C-AA To determine 
whether the incubation ofkeratinocytes with PMNs would result in 
the release of endogenous AA from keratinocytes, the cells were 
mlt1ally pre-labeled with 14C_AA (0.02I1Ci/culture) for 48 h. The 
pre-labeled cells were washed three times with 5 ml KGM prior to 
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every experiment. The labeled keratinocytes were incubated with 
PMNs and A23187 (5 11M) in KGM containing CaCI2 (0.87 mM) 
for 5 min, as described above. 
Preparation ofL TA. and Incubation with Keratinocyte Cult-
ures. The free .LTA4 was prepared from LTA4-methyl ester, as 
prevlOusly descnbed by Maycock et al [13]. Briefly, an aliquot of 
LTA4-methyl ester taken from a stock solution (10-50l1g) was 
evaporated to dryness under a stream of nitrogen. The dried L T A4-
methyl ester was treated with a mixture of 15 - 50 III of ice-cold 
MeOH and 50% sodium hydroxide (9: 1) and allowed to stand at 
4 ° C for 3 h .. Aliquots of this reaction mixture containing free LT A4 
were used directly m subsequent experiments. The pH in the cell 
cultures never exceeded 7.8 during the incubations. The L T A4 was 
freshly prepared before every experiment. 
The sub-confluent keratinocytes were pre-incubated for 10 min 
at 37°C in 3 ml ofKGM containing 0.87 mM CaCI2 and 1 mg/ml 
ofHSA. Then, LTA4 (10 11M) was added to one-half of the cultures 
and ~ncubated f~r 25 min at 37°C. For control experiments, LTA4 
was mcubated With inactivated keratinocytes and in culture medium 
(KG~,. CaCI2 , and HSA) without keratinocytes. To inactivate the 
kera~mocyt~s, cells wer~ boiled for 20 min before pre-incubation 
and I11cubatlOn. Incubations were terminated by the addition of 2 
vol of ice-cold MeOH. 
To. ascertain. whether the transformation of L T A4 into L TB4 by 
kerat1110c~tes IS catal~zed by L T A4-hydrolase, the keratinocytes 
were pre-l11cubated With bestatin (70 11M), a putative inhibitor of 
L T A4-hydrolase [20]. The inhibitor effects were evaluated at two 
time points: 15 and 60 min, respectively, prior to incubation with 
L T A4. Control experiments contained no bestatin. Incubation pro-
cedures were as described previously. 
Extr~ction of Lipids The typic.al reaction mixture was kept at 
-020 C for .1? mm and then centrifuged (1500 X g) for 10 min at 
OCto precIpitate cellular de~ri.s and denatured protein. The super-
natant was collected and the hplds extracted as previously described 
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Figure 1. Representative UV scans of authentic LTB standard and an 
eluent sample fraction that coelutes with standard LTB4 . 
VOL. 100, NO.3 MARCH 1993 
120 
110 
100 * p<O.05 
90 
80 
70 
...,. 
CD 60 ~ 
-I 
en 50 c: 
40 
30 
20 
10 
0 
KC PMN KC+PMN 
Figure 2. Fonnation of LTB. by sub-confluent keratinocytes (KC) (1.5 X 
106) alone (one culture dish, 25 cm2), PMNs alone (5 X 106 cells), and 
coincubation of sub-confluent keratinocytes (1.5 X 106) and PMNs (5 X 
106 cells). Cells were pre-incubated in KGM containing CaCI2 (0.87 mM) 
for 10 min at 37°C. Then, A23187 (5 tiM) was added, and incubations 
were carried out for an additional 5 min. LTB. fonned was determined by 
RIA after HPLC separation. Results are expressed as mean ± SEM from 
six experiments assayed in duplicate. 
[19]. The acidified supernatant (pH 3) was applied to octadecylsilyl 
silica columns (CwSep-Pak cartridges; Waters, Milford, MA) and 
eluted sequentially with 2 ml water, 2 m125% MeOH, 2 ml petro-
leum ether, and 3 ml MeOH. The MeOH fraction was taken to 
dryness under a stream of N2 and resuspended in 70% MeOH. 
Reversed-Phase High-Performance Liquid Chromato-
graphy Extracted lipids were separated by reversed-phase (RP)-
HPLC as previously described [19]. Specifically, the RP-HPLC 
consisted of two M-6000 A pumps, a Hypersil Cis-column (5 f.1.m, 
100 X 4.6-mm inner diameter), a model 490 programmable UV 
detector, a Waters 810 Baseline WD color chromatography data 
system with pump control, and a WISP autosampler. The elution 
program was a modified isocratic method using methanol/water/ 
acetic acid (70: 30: 0.01) (v Iv) as the mobile phase (solvent A). For 
the first 10 min, the flow rate was 0.80 ml/min, and thereafter the 
flow rate was increased to 1.30 ml/min. At 30 min, the mobile 
phase was changed to 100% MeOH (solvent B) for 10 min to elute 
unreacted fatty acids. Thereafter, the column was re-equilibrated 
with solvent A before the next analysis. The UV detector was pro-
grammed to 270 nm from 0 to 15 min and to 235 nm from 15 to 30 
min. The eluent was monitored by the UV detector, producing the 
UV absorption as a function of wavelength for each chromato-
graphic peak. 
Fatty acid metabolites were quantified using authentic standards 
to construct the calibration curves. The integrated areas obtained 
during analysis of the biologic samples were then converted to 
amounts by comparison with areas obtained from the authentic 
standards. These values were then converted to amount/sample and 
corrected for losses during the purification procedure. The elution 
KERATINOCYfE/PMN INTERACTION IN LTB. FORMATION 295 
200 
PMNs+KCs 
150 
~ 
ID 
t-
~ 
en 
c PMNs 
100 only 
50 
o 
o 1 2 3 4 5 6 7 8 9 10 
Number of PMNs ( X106) 
Figure 3. Effect of increasing concentrations of PMNs to a fixed number of 
keratinocytes (KCs) on LTB. fonnation. Cells were pre-incubated in KGM 
containing CaCI2 (0.87 mM) for 10 min at 37"C. Then, A23187 (5 tiM) 
was added, and incubations were carried out for an additional 5 min. LTB, 
fonned was determined by use of RP-HPLC combined with RIA. Results 
are expressed as mean ± SEM from six experiments assayed in duplicate. 
times were standardized daily. The eluent was collected by a frac-
tIOn collector programmed to collect I-min fractions. 
UV Absorbance Spectrum Formation of L TB, was identified 
by ch~racteristic ~V absorb~nce and by chromatographic compari-
son With authentiC L TB •. Figure 1 shows representative UV scans 
of authentic L TB, and an eluent fraction that cochromatographed 
with authentic L TB,. 
RIA for LTB. Fractions that cochromatographed with authentic 
LTB, were evaporated under a stream of N2 and resuspended in 
assay buffer (50 mM Tris (hydroxymethyl) aminomethane/HCI 
buffer containing 0.1 % w /v gelatine; pH 8.6). The anti-rabbit anti-
body with high specificity for LTB, was used. The antibody ex-
hibits cross-reactivity of 3.3% with diasteroisomers of 5, 12-dihy-
droxy-6,8, 1 0-tralls-14-cis-eicosatetraenoic acid (diHETE), 1.6% 
with diastereoisomers of 5,6-diHETE, 0.14% with 5 (S), 12(S)-di-
HETE, <0.03% with 5- and 15-HETE, and 2.0% with 12-HETE. 
Cross-reactivity with prostaglandin E2 and other prostaglandins was 
less than 0.03%. Dextran-coated charcoal was used to separate the 
bound from the free ligand. The RIA analyses were performed in 
accordance with the manufacturer's instructions. 
Determination ofKeratinocyte/PMN Ratios To determine 
keratinocyte/PMN ratios, DNA determinations of two representa-
tive keratinocyte culture dishes as well as ofPMNs were performed 
during every incubation procedure exactly as described previously 
[21]. Aliquots from the PMNs and representative keratinocyte cul-
ture dishes were used for cell counting. 
Keratinocyte cell number was determined in representative cul-
ture dishes because coincubation of keratinocytes and PMNs were 
carried out with the keratinocytes in the culture dishes where they 
were grown. 
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Figure 4. Representative RP-HPLC chromatograms of extracts from keratinocytes incubated in 3 ml KGM containing 0.87 mM CaCl2 and HSA (1 
mg/ml) with and withoutLTA4 (10 J.lM) for 25 minat37 ' C. UV absorbance was monitored at 270 nm from 0 to 15 min and at 235 nm from 15 t030 min. (A) Cultured keratinocytes incubated without L TA4 . (B) Cultured keratinocytes incubated with L T A4 . (C) Control; inactivated keratinocytes incubated 
with LTA4. (D) Control; LTA4 incubated without keratinocytes. 
Statistical Methods Results are expressed as the mean ± 
standard error of mean (SEM). Statistical significance was assessed 
by the Wilcoxon rank sum test. 
RESULTS 
The incubation of PMNs (5 X 106) with a culture flask (25 cm2) 
containing primary, sub-confluent keratinocytes revealed an aver-
age ratio of3: 1 for PMNs to keratinocytes, as determined by count-
ing the cells. Estimated by DNA measurements, the keratinocyte/ 
PMN ratio was approximately the same. 
Figure 2 shows the respective A23187 -induced formation of 
LTB4 by keratinocytes alone, by PMNs alone, and by coincubation 
of both cell types . Incubation of keratinocytes (1.5 X 106 cells) 
alone failed to produce detectable amounts of L TB4 ( < 2 pg/ cul-
ture dish). In contrast, PMNs (5 X 106 cells) alone produced 
62.2 ± 8.5 ng of LTB4. Of interest, the coincubation of PMNs 
with keratinocytes resulted in increased formation of LTB4 
(107.6 ± 12.0 ng) , an increase of73% over LTB4 formed by PMNs 
and keratinocytes separately. This L TB4 formation resulting from 
coincubation of keratinocytes with PMNs was significantly higher 
(p < 0.05) than the separate incubations of either of the cells. The 
L TB4 formation was determined by RP-HPLC combined with RIA 
as described in Materials and Methods. Quantification of LTB4 by 
integrated optical density was not significantly different from 
values obtained by RIA (73.6 ± 6.0 ng/5 X 106 PMNs and 
121.2 ± 9.8 ng for coincubation ofPMNs with keratinocytes). 
To determine whether the increase in LTB4 formation was 
caused by cellular factors released by keratinocytes, supernatants 
from A23187 -stimulated keratinocyte cultures were incubated with 
PMNs for 5 min. No increase in LTB4 formation was measurable in 
these experiments (data not shown). 
To investigate whether the increased L TB4 formation was caused 
by release of endogenous AA from keratinocytes, 14C_AA pre-la-
beled keratinocytes were incubated with PMNs and then stimulated 
with A23187 for 5 min. One-minute eluents were collected and 
counted for radioactivity in the scintillation counter. No radioactiv-
ity was detected in the fraction coeluting with L TB4 on the RP-
HPLC (n = 6; assayed in duplicate). 
The formation of L TB4 by cultures of primary, sub-confluent 
keratinocytes (25 cm2) that were incubated with PMNs depended 
on the number ofPMNs present (Fig 3). This increase is consistent 
with the possibility that the fixed number ofkeratinocytes possesses 
enough enzyme to transform increasing amounts ofPMN-derived 
LTA4 into LTB4. 
To determine whether keratinocytes possess the capacity to 
transform L T A4 into L TB4, the keratinocytes were incubated with 
or without LTA4. No detectable amount « 2 ng/culture dish) of 
L TB4 was formed in the absence of L T A4 (Fig 4A). In contrast, 
incubations of keratinocytes with L T A4 (10 .liM) resulted in the 
formation of 154 ± 10.2 ng LTB4. Two non-enzymatic hydrolytic 
products of LTA4 (6-trans-LTB4 and 12-epi-6-tralls-LTB4) were 
also detected (Fig 4B) . Incubation of L T A4 with inactivated kerati-
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Figure 5. Effect of bestatin on keratinocyte·catalyzed transformation of 
LTA. into LTB •. Keratinocytes (1.5 X 106) were pre-incubated with bes-
tatin for 15 or 60 min, respectively, in KGM containing CaCl2 (0.87 mM) 
and HSA (1 mg/ml) at 37°C. Control incubations contained only kerati-
nocytes and no bestatin. L TB. formation was determined by integrated 
optical density. Results are expressed as mean ± SEM from six experi-
ments assayed in duplicate. 
nocytes (boiled for 20 min) resulted in the formation of 6-trans-
LTB4 and 12-epi-6-trans-LTB4 but no detectable amount of LTB4 
(Fig 4C). The two non-enzymatic products ofLTA. were also de-
tected when L T A4 was incubated in medium that contained no 
keratinocytes, whereas no detectable amount of L TB4 was formed 
(Fig 4D). 
To delineate whether the transformation of L TA4 into L TB4 by 
cultured keratinocytes was catalyzed by the L T A4-hydrolase, kerati-
nocytes were pre-incubated with bestatin (a known inhibitor of 
LTA4-hydrolase) at 15 or 60 min, respectively, prior to incubation 
with L T A •. The data in Figure 5 revealed a bestatin-induced time-
dependent inhibition of L T A4 transformation into L TB4 by kerati-
nocytes. Of note, pre-incubation for 60 min resulted in a marked 
inhibition (60%) when compared with control. 
DISCUSSION 
In the present study, we demonstrated that the coincubation of 
human PMNs and cultured human adult keratinocytes resulted in a 
markedly increased formation of L TB4 when compared with either 
of the cells alone. This increase is probably due to keratinocyte 
transformation of PMN-derived L TA4 into L TB4. Furthermore, 
the incubation of PMNs with the medium from calcium-
ionophore - stimulated keratinocytes failed to increase L TB4 forma-
tion, indicating that soluble factors released from keratinocytes are 
probably not involved in the induced L TB4 formation. Interleukin-
8, which has been reported to stimulate L TB4 synthesis by PMNs 
[22] , is unlikely to have enhanced the L TB4 formation observed in 
this study because it is not stored in keratinocytes and because inter-
leukin-8 biosynthesis would have required longer incubation time 
[23] . 
The metabolic transformation of L T A4 into L TB4 is catalyzed by 
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the enzyme LTA4-hydrolase. Two forms ofLTA4-hydrolases have 
been described. The types described in human lung and human 
PMNs have identical molecular weight [24,25]; the other type de-
scribed in human erythrocytes [26] has a lower molecular weight. 
Both forms are differentially inhibited by bestatin, a selective inhibi-
tor of L TA4-hydrolase [20] . Prior incubation of keratinocytes with 
bestatin resulted in a time-dependent inhibition of LT A4 transfor-
mation into L TB4, indicating indirectly the existence of an LTA4-
hydrolase in human keratinocytes. This finding is in accordance 
with what was found in neutrophils [20]. The sub-cellular localiza-
tion of this enzyme in the keratinocytes remains to be determined. It 
is. interesting that its presence has been described in the cytosolic 
fractions of human erythrocytes and leukocytes [24,26]. Thus, its 
isolation and characterization in keratinocytes and epidermis seem 
warranted. 
The concept of transcellular metabolism of AA by a variety of cell 
typ~s is rev~aling interesti~g ~?operativity of cells in the generation 
of elcosanOids. Such a pOSSIbility was first descnbed in the transcel-
lular metabolism of lymphocyte-derived AA in monocytes [27]. 
More recently, it was reported that platelets [16,28], lymphocytes 
[29], erythrocytes [18], and endothelial cells [14,17,30], which ex-
press negligible 5-LO activity, can transform PMN-derived LTA. 
into LTB4 or LTC4 after coincubation of these cells with PMNs. 
These findings indicate that intermediates formed by one cell type 
can be utilized by an interacting cell to form new products. Our data 
indicate that keratinocytes that have negligible 5-LO activity pos-
sess a large capacity to transform PMN-derived LTA4 into LTB4. 
Of interest, the coincubations of a fixed number of keratinocytes 
with increasing numbers of PMNs did not alter the percentage 
increase in LTB. formation when compared with PMNs only, indi-
cating that the keratinocytes possess a large capacity of LT A4-hy-
drolase that can transform PMN-derived LTA4 into LTB4. 
Although AA released from platelets and utilized in PMNs has 
been shown to be a part of the neutrophil- platelet cell interaction, 
resulting in the increased L TB. formation [31] , the above mecha-
nism appears to differ from the keratinocyte-PMN interaction de-
scribed in this study. This assumption is based on the coincubation 
of 14C-AA-labeled keratinocytes and PMNs, which, when chal-
lenged by A23187, revealed no detectable 14C-LTB. in the fraction 
coeluting standard LTB4 on the RP-HPLC. 
In summary, our present findings demonstrate that transcellular 
metabolism of AA metabolites can occur between keratinocytes and 
PMNs. It is also likely that other cells in the epidermis can interact 
with other infiltrating leukocytes to generate novel eicosanoids. 
Our findings underscore the possibility that keratinocytes may am-
plify local epidermal LTB4 formation by utilizing PMN-derived 
LTA. during local inflammation, when PMNs migrate into the 
epide.rmis. These possibilities remain to be delineated using epider-
mal tissue from human skin to biosynthesize L TB4 by a mechanism 
similar to the isolated keratinocytes. 
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